Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Statistics

Total Valuation

HRTX has a market cap or net worth of $240.31 million. The enterprise value is $347.67 million.

Market Cap	240.31M
Enterprise Value	347.67M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

HRTX has 152.09 million shares outstanding. The number of shares has increased by 16.83% in one year.

Current Share Class	152.09M
Shares Outstanding	152.09M
Shares Change (YoY)	+16.83%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	57.19%
Float	115.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.74
Forward PS	6.31
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.28

Current Ratio	2.28
Quick Ratio	1.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.75

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-2.31%
Return on Capital (ROIC)	-3.58%
Revenue Per Employee	$1.09M
Profits Per Employee	-$221,960
Employee Count	126
Asset Turnover	0.61
Inventory Turnover	1.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.20% in the last 52 weeks. The beta is 1.69, so HRTX's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	-9.20%
50-Day Moving Average	1.57
200-Day Moving Average	2.42
Relative Strength Index (RSI)	52.30
Average Volume (20 Days)	6,172,219

Short Selling Information

The latest short interest is 27.54 million, so 18.11% of the outstanding shares have been sold short.

Short Interest	27.54M
Short Previous Month	27.91M
Short % of Shares Out	18.11%
Short % of Float	23.95%
Short Ratio (days to cover)	14.20

Income Statement

In the last 12 months, HRTX had revenue of $137.74 million and -$27.97 million in losses. Loss per share was -$0.18.

Revenue	137.74M
Gross Profit	65.36M
Operating Income	-8.32M
Pretax Income	-48.13M
Net Income	-27.97M
EBITDA	-5.70M
EBIT	-8.32M
Loss Per Share	-$0.18

Balance Sheet

The company has $70.89 million in cash and $178.25 million in debt, giving a net cash position of -$107.36 million or -$0.71 per share.

Cash & Cash Equivalents	70.89M
Total Debt	178.25M
Net Cash	-107.36M
Net Cash Per Share	-$0.71
Equity (Book Value)	-40.01M
Book Value Per Share	-0.26
Working Capital	109.64M

Cash Flow

In the last 12 months, operating cash flow was -$8.29 million and capital expenditures -$1.32 million, giving a free cash flow of -$9.61 million.

Operating Cash Flow	-8.29M
Capital Expenditures	-1.32M
Free Cash Flow	-9.61M
FCF Per Share	-$0.06

Margins

Gross margin is 47.45%, with operating and profit margins of -6.04% and -20.30%.

Gross Margin	47.45%
Operating Margin	-6.04%
Pretax Margin	-20.30%
Profit Margin	-20.30%
EBITDA Margin	-4.13%
EBIT Margin	-6.04%
FCF Margin	n/a

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.83%
Shareholder Yield	-16.83%
Earnings Yield	-11.64%
FCF Yield	-4.00%

Analyst Forecast

The average price target for HRTX is $5.67, which is 258.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.67
Price Target Difference	258.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	13.88%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 13, 2014. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 13, 2014
Split Type	Reverse
Split Ratio	0.05:1

Scores

HRTX has an Altman Z-Score of -10.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.32
Piotroski F-Score	3